MicroPort® has always been committed of constantly being at the innovative forefront to deliver best and affordable solutions that save life and improve quality of life.
Every 15 seconds, somewhere around the world, MicroPort® transforms a patient's life by bringing life-saving treatments or quality-improving care, or gives new hope of starting a family.
Global presence in 12 countries and regions
3,000 + employees worldwide
200 R&D staff in China
Over 300 employees in Marketing and Sales
MicroPort® is contributing to a better world through its life-saving medical therapies and quality-improving care devices being used in patients every 15 seconds.
MicroPort® was founded in May 1998 in ZhangJiang High Tech Park. Through years of growth and innovation, it has become a leading medical device company in China with business covering 10 major medical disciplines including cardiovascular, orthopedics, diabetes and endocrine management, electrophysiology, endovascular, neurovascular, surgical management and so on. A diverse portfolio of products are now being used every 15 seconds in over 5,000 hospitals throughout the world’s major markets including Asia, North America, South America, and Europe. MicroPort® currently has over 200 premium products, and a worldwide operation of more than 3,000 employees. A third of which are based overseas in more than twelve countries and regions like the United States, Netherlands, Italy, Germany, France, Britain, Belgium, Japan, Canada and so on.
Cardiovascular devices business offers products and services for the interventional treatment of coronary artery related diseases. We are committed to develop, manufacture and commercialize market-leading coronary stents and the delivery systems, along with dilatation catheters and accessories.
Our orthopedic devices business offers an extensive range of products that includes reconstructive joints, spine, trauma, sports medicine, and other professional implants and equipment. The orthopedics business is committed to providing innovative and effective clinical solutions to assist in the hip and knee reconstruction surgery. Its main product lines are in accordance with two major trends in the orthopedic community today, which are fast recovery and minimal invasiveness.
The endovascular devices business focuses on providing a range of products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular disease, aortic dissection, and other endovascular related diseases. As an integral part of the cardiovascular product line, the endovascular devices business provides comprehensive vascular stent and graft systems for the treatment of aortic and peripheral vascular diseases.
The primary focus of the electrophysiological (
The neurovascular devices business specializes in providing products and services for the treatment of intracranial arterial aneurysms, carotid arterial stenosis and other central nervous system related diseases. The neurovascular products offer a comprehensive line of neural stent and graft systems for the treatment of CNS diseases.
Business of surgical management focuses on extracorporeal circulation products and occlusion series products used for Congenital Heart Disease.
The diabetic and endocrinal management business primarily focuses on the development, manufacture, management and supervision of endocrine medical devices. Products include insulin pumps and pituitary hormone infusion pumps for the treatment of diabetes and gonad-related diseases respectively.